Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature PosthumaDeBoer J; Witlox MA; Kaspers GJ; van Royen BJClin Exp Metastasis 2011[Jun]; 28 (5): 493-503Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies target the primary tumour rather than metastases and have a limited efficacy in the treatment of metastatic disease. Metastatic cells have specific features that render them less sensitive to therapy and targeting these features might enhance the efficacy of current treatment. A detailed study of the biological characteristics and behaviour of metastatic OS cells may provide a rational basis for innovative treatment strategies. The aim of this review is to give an overview of the biological changes in metastatic OS cells and the preclinical and clinical efforts targeting the different steps in OS metastases and how these contribute to designing a metastasis directed treatment for OS.|*Molecular Targeted Therapy[MESH]|Antineoplastic Combined Chemotherapy Protocols/pharmacology[MESH]|Bone Neoplasms/*drug therapy/*pathology[MESH]|Humans[MESH]|Neoplasm Metastasis/*drug therapy/pathology[MESH]|Osteosarcoma/*drug therapy/*pathology[MESH] |